Firms, funds, people, portfolio companies and transactions from sworn filings and cited announcements, kept as a graph with a date and a source on every edge. Reported gross assets are never fund size, regulatory AUM is never dry powder, and a deal value prints only when someone disclosed it.

The names on this page are hidden. Create a free account and they fill in. No card, and every figure, date and source on this page is public either way.

Firms / C••• E••••• C•••••• M••••••••• L•••

C••• E••••• C•••••• M••••••••• L•••

Buyout firmLower middle marketUSc•••••••••.comSEC registered investment adviser
Classification
Class
Buyout firmconfirmed, confidence 85%
Basis
R6: 2 of 2 distinct vehicles are sworn Private Equity Funds; 2 reported gross assets on a filing in 2022 or later
Size band
Lower middle marketdefined by: proxy: $0.43bn Private Equity Fund GAV on the Form ADV filed 2024-03-29
Classification history (1)
  1. Sep 13, 2026
    Buyout firm (confirmed, 85%, cls-pe-1)
    R6: 2 of 2 distinct vehicles are sworn Private Equity Funds; 2 reported gross assets on a filing in 2022 or later
Regulatory footprint (Form ADV)
Adviser type
registered investment adviser
Form ADV filings
Dec 14, 2020 to Mar 29, 2024
RAUM
$427Mregulatory assets under management of the adviser; not dry powder, not a fund size
PE funds, latest filing
2
PE fund GAV, latest filing
$427Mreported gross assets (Form ADV), not fund size
All private fund GAV
$427Mevery private fund type, latest filing
2024 PE fund GAV
$427Msum over funds typed Private Equity Fund with a 2024 or later as-of date
PE share of funds, lifetime
100%
Fund type mix
filed 2024-03-29, latest gav Private Equity Fund $427M, latest counts Private Equity Fund 2, lifetime distinct Private Equity Fund 2
Employees
7
Business phone
908-489-7822
Stated criteria beside observed behaviour
6 observed deals
Stated by the firm
Sectors
not stated or not yet read
Geography
not stated or not yet read
Revenue
not stated or not yet read
EBITDA
not stated or not yet read
Enterprise value
not stated or not yet read
Equity check
not stated or not yet read
Control
not stated or not yet read
Thesis
C••• Equity is an investment firm that builds and invests in companies specializing in outsourced drug discovery and development services.
Observed from deals on record
roles
unknown 6
period
to unknown, from unknown, undated holdings 6, dated observations 0
window
last unknown, first unknown
control
unknown 6
companies
6
geography
investments
6
seller kinds
transactions
0
cadence by year
platform add on
add ons 0, platforms 0, add ons per platform unknown
sector known for
0
disclosed value usd
n 0
sector distribution
holding period years
n 0
repeat counterparties
subsector distribution

6 companies on the graph (0 transactions); no dated observations

Funds
2 on record
FundVehicleVintageReported gross assets (Form ADV), not fund sizeGAV by yearForm D soldLifecycle
C••• E••••• I•• L•••
ADV: Private Equity Fund
buyout or unlabelled2023
first reported on Form ADV
$302M
as of Mar 29, 2024
no Form DUnknown
C••• E•••••• L•••
ADV: Private Equity Fund
buyout or unlabelledunknown$125M
as of Mar 29, 2024
no Form DMature
Team
8 current, 0 former
Portfolio
6 relationships, 0 platforms, 0 add-ons
CompanyRoleStatusInvestedHeldPartnerSource
M••••••• B•••••••••Role unknownactiveunknownunknownunknownFact DFX graph bridge (shared CRD, CIK, EIN, SEC fund id and individual CRD across fo/isi/vc/pe)
O•• C••••Role unknownunknownunknownunknownunknownFact Investment organization websites (team, portfolio, strategy, criteria, news)
S•••••• B•••••••••Role unknownactiveunknownunknownunknownFact DFX graph bridge (shared CRD, CIK, EIN, SEC fund id and individual CRD across fo/isi/vc/pe)
S••••• C••• D•••••••••Role unknownactiveunknownunknownunknownFact DFX graph bridge (shared CRD, CIK, EIN, SEC fund id and individual CRD across fo/isi/vc/pe)
T•••• B••••••••Role unknownactiveunknownunknownunknownFact DFX graph bridge (shared CRD, CIK, EIN, SEC fund id and individual CRD across fo/isi/vc/pe)
T•••• o• U••Role unknownunknownunknownunknownunknownFact Investment organization websites (team, portfolio, strategy, criteria, news)
Transactions
0 on record
No transaction naming this firm has been collected yet. The deal tape is read from SEC filings and cited announcements.
Placement agents, lenders, advisers and co-investors
1 relationships
Placement agents (1)
  • P••••••• C•••••• L•• 2 shared · recurring · last Jan 1, 2023
LP commitments
0 disclosed
No LP commitment collected yet. An LP edge needs a public disclosure with a quote, such as a pension plan’s report or an announcement naming the LP.
Events
5 most recent
  1. Sep 17, 2026
    M••••••• Biotechnologies Announces Acquisition of OmicScouts
    Firm newsFactInvestment organization websites (team, portfolio, strategy, criteria, news)
  2. Sep 17, 2026
    S•••••• Partners with Alamar Biosciences to Extend Targeted Proteomics Services Using NULISA™ Assays for Cytokines, Chemokines, and Inflammatory Mediators
    Firm newsFactInvestment organization websites (team, portfolio, strategy, criteria, news)
  3. Sep 17, 2026
    S•••••• Partners with Rancho BioSciences to Accelerate the Next Generation of its Human Biology Database
    Firm newsFactInvestment organization websites (team, portfolio, strategy, criteria, news)
  4. Sep 17, 2026
    S•••••• Appoints Jonathan Usuka as Chief Business Officer
    Firm newsFactInvestment organization websites (team, portfolio, strategy, criteria, news)
  5. Dec 14, 2020
    C••• E••••• C•••••• M••••••••• L••• first filed Form ADV in the extract (ERA)
    First Form ADV filingFactSEC Form ADV filing data 2011 to 2024 (Schedule D 7.B.(1) private funds, Schedules A/B, 1.I websites)
Across the graphs

C••• E••••• C•••••• M••••••••• L••• is the same institution as 2 records in Venture Capital and RIA and Wealth.

Venture Capital1RIA and Wealth1

Which record it is in each graph, what it is called there, and what the two were joined on. The Data Factory holds all nine graphs and the identity layer between them.

Checking your plan…